Advertisement

Long-Term Course of Gastric Submucosal Tumors: Growth Speed and Size-Increasing Factors

Published:January 15, 2023DOI:https://doi.org/10.1016/j.gie.2023.01.020
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Backgrounds and study aims

      Gastric submucosal tumors (SMTs) are treated or monitored according to gastrointestinal stromal tumor (GIST) guidelines, but their adequacy has not been thoroughly investigated. We investigated the long-term course of gastric SMTs to determine the validity of guideline-based follow-up methods and the factors contributing to their size increase.

      Methods

      In the study, gastric SMTs diagnosed as gastrointestinal mesenchymal tumors (GIMTs) by endoscopic ultrasonography (EUS) and followed up with EUS were included. The percentage and speed of GIMT enlargement and factors associated with the enlargement were investigated using the Cox proportional hazards model.

      Results

      From January 1994 to May 2022, 925 gastric SMTs were evaluated with esophagogastroduodenoscopy (EGD), and 231 SMTs were diagnosed with GIMTs. Of the 231 GIMTs, 145 were examined by EUS more than twice and were followed up on for more than 6 months. The mean follow-up period was 5.20 ± 4.04 years (0.5–17.3 years), with 39 of 145 GIMTs (26.9%) increasing in size with a doubling time of 3.60 ± 3.37 years. A multivariate analysis of factors influencing tumor growth revealed that irregular extraluminal borders were an increasing factor (hazard ratio [HR]: 3.65, 95% CI: 1.26–10.52), initial tumor size of 9.5 mm or less (HR: 0.23, 95% CI: 0.07–0.77) was a non-increasing factor, and GIMTs with calcification (n = 13) did not increase in size.

      Conclusions

      Tumor growth in gastric GIMTs less than 9.5 mm in diameter and/or with calcification is rare. Follow-up intervals for these lesions could be extended.

      Acronyms and abbreviations:

      SMT (submucosal tumor), GIST (gastrointestinal stromal tumor), GIMT (gastrointestinal mesenchymal tumor), EUS (endoscopic ultrasonography), EGD (esophagogastroduodenoscopy), HR (hazard ratio), NCCN (National Comprehensive Cancer Network), ESMO (European Society for Medical Oncology), DT (doubling time), SD (standard deviation), ROC (Receiver operating characteristic), FNA (fine needle aspiration (FNA)), CT (computed tomography)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect